Unknown PHASE2/PHASE3 INTERVENTIONAL NCT00182182

Evaluation of a Primary Care Based Heart Failure Management Program

Congestive Heart Failure Assessment and Management in Primary Care: CHAMP

Sponsor: Hamilton Health Sciences Corporation

Interventions Primary care based disease management strategy

Updated 5 times since 2017 Last updated: Sep 8, 2006 Started: Jul 31, 2003 Completion: Oct 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2/PHASE3 clinical study on Heart Failure, this trial is ongoing. The trial is conducted by Hamilton Health Sciences Corporation and has accumulated 5 data snapshots since 2003. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2/PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2/PHASE3

Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE2_PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE2_PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

First recorded

Jul 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hamilton Health Sciences Corporation
Heart and Stroke Foundation of Canada

Data source: McMaster University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Hamilton, Canada